All In MedTech

FDA Clearance Tracker · P830055-S334

Attune Primary System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 20, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 20, 2025

Approved

Time to decision

146 days

Received Sep 27, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P830055-S334
Device name
Attune Primary System
Applicant
Depuy, Inc.
Applicant location
Warsaw, IN
Received
Sep 27, 2024
Decided
Feb 20, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P830055

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

Approval for two changes: i) change in the manufacturing consolidation process of antioxidant (Pentaerythritol tetrakis [3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate]) (AOX), Ultra-High Molecular Weight Polyethylene (UHMWPE) bar stock material for the Attune Cruciate Retaining Rotating Platform (CR RP) and the Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components that belong to the Attune Primary System.ii) change in the sterilization process of the Attune Cruciate Retaining Rotating Platform (CR RP), Attune Posterior Stabilized Rotating Platform (PS RP) tibial inserts components and the Attune Medialized Anatomic and Medialized Dome Patellar Components that belong to the Attune Primary System from a single, high dose sterilization to a split-dose sterilization method through a combination of crosslinking AOX UHMWPE raw material and final terminal sterilization

Source documents

Other decisions for Depuy, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.